Advisors Asset Management Inc. Has $10.48 Million Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Advisors Asset Management Inc. increased its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 8.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,123,668 shares of the pharmacy operator’s stock after purchasing an additional 91,551 shares during the period. Advisors Asset Management Inc. owned approximately 0.13% of Walgreens Boots Alliance worth $10,484,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Kennondale Capital Management LLC bought a new position in Walgreens Boots Alliance in the fourth quarter valued at approximately $1,050,000. Signaturefd LLC increased its stake in Walgreens Boots Alliance by 12.3% in the 4th quarter. Signaturefd LLC now owns 15,417 shares of the pharmacy operator’s stock valued at $144,000 after buying an additional 1,692 shares during the last quarter. Cibc World Markets Corp increased its stake in Walgreens Boots Alliance by 15.2% in the 4th quarter. Cibc World Markets Corp now owns 282,286 shares of the pharmacy operator’s stock valued at $2,634,000 after buying an additional 37,141 shares during the last quarter. Harbour Investments Inc. increased its stake in shares of Walgreens Boots Alliance by 4.3% during the 4th quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator’s stock worth $265,000 after purchasing an additional 1,165 shares during the last quarter. Finally, Corient Private Wealth LLC increased its stake in shares of Walgreens Boots Alliance by 4.0% during the 4th quarter. Corient Private Wealth LLC now owns 282,798 shares of the pharmacy operator’s stock worth $2,639,000 after purchasing an additional 10,772 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on WBA. StockNews.com started coverage on shares of Walgreens Boots Alliance in a report on Tuesday. They set a “hold” rating for the company. Royal Bank of Canada upped their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Truist Financial decreased their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Bank of America upped their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their price objective for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $11.54.

Walgreens Boots Alliance Price Performance

WBA stock opened at $11.26 on Tuesday. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.05. The firm has a market capitalization of $9.73 billion, a P/E ratio of -1.10, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The firm has a 50 day moving average of $10.86 and a 200-day moving average of $9.77.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.66 earnings per share. As a group, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.